Comments
Natco Pharma today reported 32.88 per cent increase in consolidated net profit at Rs 22.59 crore for its third quarter ended December 31.
The company had posted net profit of Rs 17 crore in the same period last fiscal, Natco said in a filing to the BSE.
Consolidated net sales of the company rose to Rs 157.78 crore for the third quarter, as against Rs 129.31 crore in the corresponding period of the 2011-12 fiscal.
The company’s board approved an interim dividend of Rs 4 per equity share payable on March 6, it added.
Natco Pharma scrip closed at Rs 455.60 on the BSE, up 0.64 per cent from its previous close.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.